NFL Biosciences SAS (ALNFL) — Cash Flow-to-Debt Ratio
NFL Biosciences SAS (ALNFL) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €57.51K could theoretically repay 0% of its total liabilities (€3.67 Million) in one year. See free cash flow generation of NFL Biosciences SAS to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NFL Biosciences SAS Cash Flow-to-Debt Ratio (2020–2022)
Historical debt coverage capacity for NFL Biosciences SAS across 3 annual periods. Also explore net asset momentum of NFL Biosciences SAS to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NFL Biosciences SAS (2020–2022)
Year-by-year debt coverage analysis for NFL Biosciences SAS. For market capitalisation and broader financial context, see NFL Biosciences SAS market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | 0.07x | €104.89K | €1.55 Million | ▼ -69.1% |
| 2021 | 0.22x | €87.00K | €397.73K | ▲ +11.2% |
| 2020 | 0.20x | €83.91K | €426.61K | — |